Ironwood Pharmaceuticals Inc (IRWD) — Financial Flexibility Index
Ironwood Pharmaceuticals Inc (IRWD) has a Financial Flexibility Index of 0.01x as of March 2026. Free cash flow of $5.12 Million (operating CF $5.12 Million minus capex $0.00) represents 0% of total liabilities ($651.71 Million). Check Ironwood Pharmaceuticals Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ironwood Pharmaceuticals Inc Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Ironwood Pharmaceuticals Inc across 19 annual periods. See Ironwood Pharmaceuticals Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Ironwood Pharmaceuticals Inc (2007–2025)
Year-by-year free cash flow to debt coverage for Ironwood Pharmaceuticals Inc. For the full company profile including market capitalisation, see market cap of Ironwood Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | $127.08 Million | $127.04 Million | $658.74 Million | ▲ +21.3% |
| 2024 | 0.16x | $103.69 Million | $103.55 Million | $652.24 Million | ▼ -29.3% |
| 2023 | 0.22x | $183.70 Million | $183.43 Million | $817.37 Million | ▼ -63.2% |
| 2022 | 0.61x | $273.90 Million | $273.76 Million | $448.14 Million | ▲ +21.5% |
| 2021 | 0.50x | $262.16 Million | $261.89 Million | $521.02 Million | ▲ +46.4% |
| 2020 | 0.34x | $170.68 Million | $168.84 Million | $496.60 Million | ▲ +851.6% |
| 2019 | 0.04x | $17.91 Million | $10.72 Million | $496.00 Million | ▲ +130.7% |
| 2018 | -0.12x | $-62.26 Million | $-70.88 Million | $528.42 Million | ▲ +26.4% |
| 2017 | -0.16x | $-95.35 Million | $-99.56 Million | $595.83 Million | ▼ -230.7% |
| 2016 | 0.12x | $78.77 Million | $-25.43 Million | $643.11 Million | ▲ +162.4% |
| 2015 | -0.20x | $-102.88 Million | $-106.93 Million | $524.00 Million | ▲ +68.4% |
| 2014 | -0.62x | $-152.03 Million | $-155.57 Million | $244.96 Million | ▲ +43.4% |
| 2013 | -1.10x | $-263.76 Million | $-273.36 Million | $240.74 Million | ▼ -69.0% |
| 2012 | -0.65x | $-55.65 Million | $-69.63 Million | $85.86 Million | ▲ +2.0% |
| 2011 | -0.66x | $-65.56 Million | $-75.24 Million | $99.12 Million | ▼ -85.1% |
| 2010 | -0.36x | $-50.68 Million | $-67.90 Million | $141.81 Million | ▼ -350460.4% |
| 2009 | 0.00x | $47.00K | $-4.00 Million | $460.79 Million | ▲ +100.7% |
| 2008 | -0.01x | $-5.26 Million | $-28.20 Million | $371.13 Million | ▼ -8.4% |
| 2007 | -0.01x | $-4.11 Million | $-6.76 Million | $314.28 Million | — |